Several Indian companies, including Larsen & Toubro, Godrej Consumer Products, and Dr Reddy’s Laboratories, are expected to record double-digit growth in their topline and bottomline figures for the March quarter due to healthy execution and strong order books. L&T’s core engineering business is expected to drive the topline with a healthy opening order book. Meanwhile, Revlimid, the cancer drug, is expected to have contributed significantly to growth in Dr Reddy’s US sales.
Warren Buffett’s 7 golden rules for young investors trying to manage finances
Warren Buffett shares seven essential financial lessons for young investors, emphasising frugal living, eliminating high-interest debt, long-term investing, understanding businesses, maintaining cash reserves and portfolio
November 10, 2026